MARKET

AMRN

AMRN

Amarin
NASDAQ
14.06
-0.12
-0.85%
After Hours: 14.06 0 0.00% 16:00 03/06 EST
OPEN
13.98
PREV CLOSE
14.18
HIGH
14.23
LOW
13.71
VOLUME
47.85K
TURNOVER
--
52 WEEK HIGH
20.90
52 WEEK LOW
7.08
MARKET CAP
292.50M
P/E (TTM)
-7.5191
1D
5D
1M
3M
1Y
5Y
1D
Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk
TipRanks · 4d ago
Amarin Earnings Call: Cost Cuts, Cash, and Crosswinds
TipRanks · 6d ago
Amarin highlights recent data published on REDUCE-IT study
TipRanks · 6d ago
Amarin Published Data In The European Journal Of Preventive Cardiology Showing That VASCEPA Was Associated With Fewer Hospitalizations In A REDUCE-IT Analysis
Benzinga · 6d ago
Amarin post hoc REDUCE-IT analysis links icosapent ethyl to fewer hospitalizations and fewer days lost to hospitalization and death
Reuters · 6d ago
Weekly Report: what happened at AMRN last week (0223-0227)?
Weekly Report · 6d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amarin (AMRN), Ionis Pharmaceuticals (IONS) and Repligen (RGEN)
TipRanks · 02/26 12:30
Amarin down as topline contracts in Q4
Seeking Alpha · 02/25 15:17
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation PLC stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.